ORIGINAL RESEARCH article

Front. Neurol.

Sec. Stroke

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1568572

Effect of Early Neuroendovascular Team Involvement in Acute Stroke Protocol: A Retrospective Study

Provisionally accepted
  • 1Department of Emergency and Critical Care Medicine, Hachinohe City Hospital, Hachinohe, Aomori, Japan, Department of Emergency and Critical Care Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan
  • 2Department of Emergency and Critical Care Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan
  • 3Department of Neurosurgery, Hachinohe City Hospital, Hachinohe, Aomori, Japan, Hachinohe, Japan
  • 4Department of Emergency and Critical Care Medicine, Hachinohe City Hospital, Hachinohe, Japan

The final, formatted version of the article will be published soon.

Introduction: Acute ischemic stroke (AIS) is a leading cause of morbidity and mortality, with outcomes dependent on timely treatment. Tissue plasminogen activator (tPA) and endovascular therapy (EVT) improve outcomes, but delays reduce their efficacy. This study introduced a protocol featuring early participation of neuroendovascular interventionists and evaluated its association with treatment times and outcomes compared with conventional management. Methods: This singlecenter retrospective study included patients with AIS transported to emergency room (ER) who received tPA or EVT between January 2010 and December 2022. Under the protocol, the stroke team-including neuroendovascular interventionists, who made the final decision on tPA and EVTwas activated by the emergency physician when stroke was suspected based on pre-hospital information. The stroke team was not activated if neuroendovascular interventionists were engaged in other procedures or if the ER physician suspected a non-stroke diagnosis. Upon arrival, the team commenced care, with neuroendovascular interventionists reviewing imaging and determining treatment strategies. Patients were categorized into protocol and conventional groups based on management under the new protocol or standard care. The primary outcome was a favorable neurological outcome, defined as a modified Rankin Scale (mRS) score of 0-2 at discharge. Secondary outcomes included time metrics for initiation of tPA and/or EVT. Logistic regression analysis estimated the effects of the protocol, adjusting for confounders, including age, sex, baseline National Institutes of Health Stroke Scale score, and pre-hospital factors. Secondary outcomes were assessed using multiple linear regression. Results: This study analyzed 501 patients, with 313 in the protocol group and 188 in the conventional group. Favorable neurological outcomes at discharge (mRS 0-2) were more frequent in the protocol group (44.4% vs. 31.9%; adjusted odds ratio: 2.92, 95% confidence interval [CI]: 1.83-4.66). The protocol group also showed shorter door-to-imaging time (-8.3 min), door-to-needle time (-55.9 min), door-to-puncture time (-59.8 min), and door-torecanalization time (-73.7 min). Conclusions: Early engagement of neuroendovascular specialists in the emergency pathway was associated with faster treatment initiation and a higher likelihood of favorable functional status at discharge in this retrospective cohort. Because residual confounding and temporal changes in stroke care cannot be excluded, prospective validation in other settings is warranted.

Keywords: stroke team protocol, Tissue plasminogen activator (tPA), Endovascular therapy (EVT), neurological outcomes, Workflow optimization, door-to-treatment time

Received: 30 Jan 2025; Accepted: 30 May 2025.

Copyright: © 2025 MORI, Kashiura, Suzuki, Ono, Yoshimura and Moriya. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: HITOSHI MORI, Department of Emergency and Critical Care Medicine, Hachinohe City Hospital, Hachinohe, Aomori, Japan, Department of Emergency and Critical Care Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.